• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

International sales propel Imatron to fourth straight profitable quarter

Article

Firm takes over some distribution from Siemens The good times continue to roll at ultrafast CT developer Imatron.The South San Francisco, CA, company last month announced itsfourth consecutive profitable quarter, with record revenues andan

Firm takes over some distribution from Siemens

The good times continue to roll at ultrafast CT developer Imatron.The South San Francisco, CA, company last month announced itsfourth consecutive profitable quarter, with record revenues andan $800,000 improvement in earnings over the same period lastyear.

Imatron has enjoyed growing demand this year for its ultrafastCT technology after sluggish years in 1992 and 1993. Several recentlyreleased studies have supported the clinical utility of its technologyin detecting early stages of coronary artery disease in asymptomaticpatients (SCAN 9/14/94).

The Pacific Rim in particular has been a hot spot for Imatron.The company last month landed a $4.5 million contract from Thailandand a $2.5 million order from Taiwan for C-150 scanners.

Imatron's revenues for the third quarter (end-September) were$8.9 million, a company record that reflected the shipment offive C-150 systems. The figure is 4% higher than the $8.6 millionposted in the third quarter of 1993. The numbers do not includerevenue from the Thailand and Taiwan sales, which will registerin the company's fourth quarter.

Imatron's earnings present an even rosier picture. The companyhad net income for the quarter of $582,000, compared to a lossof $223,000 in the same period last year. The firm's operatingprofit was $711,000.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.